The role of serum PSA as a biomarker for prostate cancer diagnosis, prognosis, treatment monitoring as well as survival evaluation is well established 30–32; thus, the decline in PSA noted in this study was expected after orchidectomy due to loss of androgen trophism 33. The gene discussed is KLK3; the disease is prostate carcinoma.